-
Mashup Score: 9Updating cancer research with patient-focused networks - 6 month(s) ago
Multidisciplinary patient-centered networks offer access to difficult-to-get samples and initiate projects from human material. Improving such network…
Source: www.sciencedirect.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Prevalence and Prognostic Significance of Malnutrition in Patients with Brain Metastasis - 1 year(s) ago
AbstractBackground:. Malnutrition is a severe but modifiable risk factor for cancers. However, the relationship between malnutrition and the survival of patients with brain metastases has not been fully revealed. We aimed to evaluate the prevalence of malnutrition and assess its prognostic value on patients with brain metastasesMethods:. We retrospectively recruited 2,633 patients with brain…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ICYMI— Prevalence and Prognostic Significance of Malnutrition in Patients with #BrainMetastasis. First author, Dr. Zheran Liu, pictured alongside poster, at #AACR23. https://t.co/EP3t1DKedf https://t.co/Z82MllS4nw https://t.co/bT75bBFutu
-
-
Mashup Score: 1Melanoma-Secreted Amyloid Beta Suppresses Neuroinflammation and Promotes Brain Metastasis - 1 year(s) ago
Melanoma-secreted amyloid beta, which suppresses inflammatory activation of astrocytes and microglia, is required for the growth and survival of melanoma cells within the brain, and pharmacologic inhibition of amyloid beta production significantly reduced brain metastatic burden in mice.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Melanoma-secreted #AmyloidBeta Suppresses Neuroinflammation and Promotes #BrainMetastasis, by Kevin Kleffman, Eva Hernando et al. https://t.co/8o5lfuLxQ7 @nyulangone —Cancer Discovery top tweets of 2022 https://t.co/wVFFnyfXKy
-
-
Mashup Score: 2
Abstract. Trastuzumab deruxtecan is an HER 2-directed antibody-drug conjugate with ability to cross the blood-tumor barrier and activity on brain metastases. To test the activity of new drugs patient-derived xenografts (PDX) models from human brain metastases and phase 0 and window of opportunity trials are of utmost importance.
Categories: Hem/Oncs, Latest HeadlinesTweet-
RT @EANOassociation: #BrainMetastasis from #HER2-positive breast cancer: an evolving landscape. https://t.co/PprOsiAoeE #btsm #bcsm @CCR_AA…
-
-
Mashup Score: 3How to select treatment for HER2+ breast cancer patients with brain metastasis? | OncologyPRO - 1 year(s) ago
OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts,
Source: oncologypro.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
ESMO 'How To' video series: @nlinmd on initial clinical & imaging assessment for pts w/ #HER2+ #breastcancer w/ #brainmetastasis - factors to take into account when deciding between radiotherapy & systemic tx, current therapeutic options, & more https://t.co/IuyIeyFWNG #bcsm https://t.co/HX5VnmIYJ5
-
-
Mashup Score: 1Integrated Multidisciplinary Brain Metastasis Care Reduces Patient Visits and Shortens Time to Adjuvant Irradiation - 2 year(s) ago
PURPOSE: Timely surgical cavity stereotactic radiosurgery (SRS) is an important adjuvant to brain metastasis resection, with earlier treatment associated with less frequent recurrence. The logistical complexity of treatment organization, however, has resulted in suboptimal start times postsurgically. We implemented a process improvement approach to reduce the time from surgery to adjuvant…
Source: JCO Oncology PracticeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
What’s 🔥 this Week @JCOOP_ASCO? Multidisciplinary care coordination implementation for pts w/ #brainmetastasis reduced BOTH patient & health care system burden. This approach may benefit other early postop SRS #radiation scenarios. ☢️🧠 📲Read more: https://t.co/osqNf8jJLI https://t.co/TvwpQ3qkNd
-
-
Mashup Score: 2Incidence of Brain Metastasis in Breast Cancer Varies by Subtype - 2 year(s) ago
Patients with ERBB2+/HR- breast cancer had the highest incidence of brain metastasis, and patients with ERBB2-/HR+ breast cancer had the lowest incidence.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
RT @IBCResearch: Incidence of #BrainMetastasis in #BreastCancer Varies by Subtype #BCSM @OncoAlert @mbcalliance https://t.co/dzXaJVIvm5
-
-
Mashup Score: 0Incidence of Brain Metastasis in Breast Cancer Varies by Subtype - 2 year(s) ago
Patients with ERBB2+/HR- breast cancer had the highest incidence of brain metastasis, and patients with ERBB2-/HR+ breast cancer had the lowest incidence.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The incidence of #brainMetastasis in patients with #breastcancer varies by disease subtype, according to research published in @JAMANetworkOpen. https://t.co/ErdEq7mX8N #BCSM
-
-
Mashup Score: 3Socioeconomic Disparities in Brain Metastasis Survival and Treatment: A Population-Based Study - PubMed - 2 year(s) ago
In a large, population-based analysis of brain metastasis patients, we found significant differences in treatment access and mild survival differences along socioeconomic strata. More specifically, patients in lower SES tiers suffered worse outcomes and received radiation and chemotherapy less frequ …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
SCI member @HaydenGephartMD and team found significant differences in treatment access and mild survival differences along socioeconomic status in patients with #BrainMetastasis. https://t.co/OONrBZisA1 @ARodrigues121 #cancerdisparities
-
-
Mashup Score: 0Potential Effects of Lowering Colorectal Cancer Screening Age to 45 Years on Colonoscopy Demand, Case Mix, and Adenoma Detection Rate - PubMed - 2 year(s) ago
Potential Effects of Lowering Colorectal Cancer Screening Age to 45 Years on Colonoscopy Demand, Case Mix, and Adenoma Detection Rate
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
SCI member @HaydenGephartMD and team found significant differences in treatment access and mild survival differences along socioeconomic status in patients with #BrainMetastasis. https://t.co/9WlNKD55sg @ARodrigues121 #cancerdisparities
-
World's first collection of #brainMetastasis living samples will help treat each patient with the most effective therapy @CNIO_Cancer https://t.co/6XPxsJb73S https://t.co/P5JeJ9APAZ